Immix Biopharma
IMMX
Immix Biopharma (IMMX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Needham | Maintained | Buy | $30.00 from $21.00 | Sep 29, 2026 |
| Mizuho | Maintained | Outperform | $26.00 from $15.00 | Sep 15, 2026 |
| Morgan Stanley | Maintained | Overweight | $19.00 from $20.00 | Aug 11, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $25.00 from $20.00 | Aug 10, 2026 |
| Needham | Initiated Coverage | Buy | $21.00 | Jul 22, 2026 |
| B of A Securities | Initiated Coverage | Buy | $27.00 | Jun 18, 2026 |
| LifeSci Capital | Initiated Coverage | Outperform | $19.00 | Jun 17, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 from $15.00 | May 22, 2026 |
| Mizuho | Maintained | Outperform | $15.00 from $14.00 | Mar 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Mar 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 from $12.00 | Mar 27, 2026 |
| Citizens | Maintained | Market Outperform | $23.00 | Mar 27, 2026 |
| Morgan Stanley | Initiated Coverage | Overweight | $20.00 | Mar 25, 2026 |
| Citizens | Initiated Coverage | Market Outperform | $23.00 | Mar 9, 2026 |
| Mizuho | Initiated Coverage | Outperform | $14.00 | Feb 9, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 from $8.00 | Dec 9, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 from $7.00 | Sep 12, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Jun 4, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Feb 10, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Jan 6, 2025 |
Frequently asked questions
What is the latest analyst rating on IMMX?
On Sep 29, 2026, Needham maintained Immix Biopharma at Buy with a price target of $30.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.